Skip to content

Findings
Sufficient resources must be allocated, including infrastructure costs, training, and site reimbursement, to ensure smooth PT deployment.
PTs must be intuitive, validated, and able to withstand technical or environmental challenges to avoid burdening patients and sites.
PTs must comply with data privacy laws (e.g., GDPR, HIPAA) and regulatory standards (e.g., 21 CFR Part 11), and address import restrictions and age limitations.
Scaling PTs requires plans for device maintenance, multilingual support, and consistent availability across geographies and populations.
Sites need adequate training, realistic responsibilities, and clear workflows to avoid overburdening site staff and ensure patient compliance.

Recommendations
Involve key stakeholders (e.g., clinical technologies, regulatory affairs, site relations) early in the planning process to address potential challenges.
Identify risks related to usability, compliance, and data integrity, and establish mitigation strategies before implementation.
Provide tailored training materials for patients and site staff, ensuring clarity and accessibility in multiple formats and languages.
Develop Clear Vendor Contracts: Clearly outline responsibilities for maintenance, data management, and support in vendor contracts to avoid operational ambiguities.
Create Scalability Plans: Address challenges like multilingual support, long-term device maintenance, and cross-region deployment during the initial planning stages.

Regulatory Considerations
Ensure PTs comply with GDPR, HIPAA, and other relevant data protection regulations, particularly in global trials.
Verify if PTs qualify as medical devices and adhere to corresponding regulatory frameworks.
Assess and plan for country-specific import restrictions and data privacy laws to avoid delays.
Validate PTs according to Good Clinical Practice (GCP) guidelines, ensuring reliable data generation and compliance with regulatory standards.
Account for age-related legal restrictions, ensuring PTs are suitable for all intended patient populations.